Retrouvez ci-dessous la veille bibliographique élaborée par notre groupe pour le mois d’octobre 2024 !

• Anthracycline Cardiotoxicity in Adult Cancer Patients: JACC: CardioOncology State-of-the-Art Review | Lire l’article JACC
• Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score | Lire l’article European Heart Journal
• Cancer Survivors and Cardiovascular Risk: What Patients Should Know From the Perspective of Another Survivor | Lire l’article JACC
• Cardiovascular Considerations Before Cancer Therapy | Lire l’article JACC
• Life’s Essential 8 and Incident Cardiovascular Disease in U.S. Women With Breast Cancer | Lire l’article JACC
• SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes | Lire l’article JACC
• Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial | Lire l’article European Heart Journal
• The Effect of Semaglutide on Mortality and COVID-19-Related Deaths – An Analysis From the SELECT Trial | Lire l’article JACC
• Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors | Lire l’article JACC